Earnings guidance rises, but commercial medical costs stay high
- Management raised 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00.
- Medicare Advantage is performing better than planned, with 2026 margins expected above 3 percent.
- Commercial medical cost trends are running above 11 percent, pushed up by provider billing practices.
- The company expects Medicare Advantage membership to drop by about 1.1 million as it protects margins.
- UnitedHealth pledged to voluntarily rebate 2026 profits on its individual exchange products to customers.
A complicated but working recovery
UnitedHealth is recovering from a difficult 2025 where it misjudged medical costs. The turnaround plan is gaining traction. Management recently raised full-year 2026 adjusted earnings per share guidance to a range of $19.50 to $20.00, driven by stronger performance in Medicare Advantage and the Optum Health care delivery business.
The bull case focuses on execution. The company is actively shedding unprofitable Medicare Advantage members, changing benefit designs, and tightening its provider networks. Early results show Medicare Advantage margins are on track to exceed 3 percent in 2026. Optum Health is also making progress on its operational reset.
The bear case remains tied to stubborn commercial medical costs. These costs are running above 11 percent, largely due to out-of-network providers exploiting the No Surprises Act dispute resolution process. Management has warned that this sticky inflation will delay full margin recovery in the commercial business past 2027.
Finn views the recovery as real but uneven. The company has scale and a clear path to fix its government business, but the commercial cost drag will require careful monitoring.
Insurance premiums and health services
UnitedHealth generates revenue through two main segments. UnitedHealthcare sells health insurance to employers, individuals, and government programs. The primary source of income is premiums, and profitability depends on keeping medical claims below those collected premiums.
Optum is the health services division. It includes Optum Health for direct patient care, Optum Rx for pharmacy benefit management, and Optum Insight for data and technology services. Optum earns money through service fees, product sales, and risk-based contracts.
The model creates a wide moat when the two sides work together. Optum helps manage care and drug costs for UnitedHealthcare members, keeping premiums competitive. However, regulatory scrutiny is high. In response, Optum Rx is shifting to a model where it passes 100 percent of negotiated drug rebates back to clients by 2028, and UnitedHealthcare has pledged to rebate 2026 profits from its individual exchange plans.
Where UnitedHealth competes
UnitedHealthcare Employer and Individual
This commercial insurance business is large, but current medical cost trends are above 11 percent. The company is also voluntarily rebating 2026 profits on individual exchange products.
UnitedHealthcare Medicare Advantage
These are private Medicare plans for seniors. UnitedHealth expects about 1.1 million fewer members in 2026 as it exits unprofitable segments to protect margins.
UnitedHealthcare Medicaid
This business manages care for state Medicaid programs. It faces pressure from rising behavioral and pharmacy costs, plus delays in state rate updates.
Optum Health
Optum Health provides direct care and value-based care. The operational turnaround is working, though some restructuring efforts have shifted into the second half of 2026.
Optum Rx
Optum Rx manages pharmacy benefits and specialty pharmacy services. It expects to end 2026 with more than 95 percent of clients on a full rebate pass-through model.
Optum Insight
Optum Insight sells data, software, analytics, and consulting. The segment now includes Optum Financial, which was moved over from Optum Health in early 2026.
Insurance drives the revenue mix
Segment mix uses Q1 2026 unaffiliated customer revenue from the 10-Q filing. Optum revenue from UnitedHealthcare is excluded to avoid double counting.
What could break the recovery
Commercial cost inflation
High impact · High oddsCommercial cost trends are above 11 percent. Management points to the No Surprises Act independent dispute resolution process and aggressive provider billing as key causes. If this structural friction continues, commercial margins will remain depressed past 2027.
Medical cost mispricing
High impact · Medium oddsUnitedHealth only earns a profit if premiums cover the actual cost of care. The company already missed badly on pricing in 2025. A second failure to accurately forecast medical utilization would destroy trust in the current earnings floor.
Optum Health execution risk
Medium impact · Medium oddsOptum Health is fixing its value-based care strategy after growing too fast and taking on the wrong risks. The segment is narrowing provider networks and shifting some restructuring into the second half of 2026. Delays in this process could stall earnings growth.
Regulatory and legal action
High impact · Medium oddsThe company faces heavy regulation across insurance, pharmacy, and care delivery. It is routinely subject to antitrust probes, False Claims Act lawsuits, and Medicare coding audits. Significant penalties or forced changes to business practices could lower long-term earnings power.
In one breath
What does UnitedHealth actually do?
UnitedHealth sells health insurance through UnitedHealthcare and runs health services through Optum. Optum includes care delivery, pharmacy benefit management, and data and technology services.
Why did UnitedHealth have to reset its business in 2026?
Medical costs ran much higher than the company expected in 2025. Management had to cut weaker membership, change benefits, tighten networks, and focus strictly on margin recovery for 2026.
What is the biggest thing to watch now?
Watch whether commercial medical cost trends cool down. Medicare Advantage margins are improving, but commercial costs are still running high and could delay overall margin recovery.
Is Optum good or bad for UnitedHealth?
Optum is a major strength because it lowers care and drug costs for clients. It is also a risk because Optum Health has complex contracts, and Optum Rx faces intense pricing scrutiny.
Sources and research notes
This page combines Finn's company research with public filings and other cited materials. The thesis is reviewed when material company information changes; Finn Scores use the latest available scoring data.
- Thesis reviewed
- September 13, 2026
- Score data
- September 27, 2026
- Reviewed by
- Shivam Bharuka
Comparable Healthcare Plans companies
Companies near UnitedHealth Group Incorporated in Finn's Healthcare Plans industry ranking.
